Publications
170
Citations
5,839
Est. group size
~9
Recurring co-author estimate
Active years
39
Publishing since 1987
Typically publishes in teams of ~10 · 4% small-team papers (≤3 authors) · across 27 venues
- Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
Molecular Cancer Therapeutics · 2025
- Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndrome
Science Advances · 2025
- Editorial: Exploring the molecular mechanisms that regulate macrophage polarization
Frontiers in Immunology · 2025
- Data from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S5 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S3 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S1 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S6 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S4 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S2 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S7 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Supplementary Figure S8 from Histotripsy-Focused Ultrasound Treatment Abrogates Tumor Hypoxia Responses and Stimulates Antitumor Immune Responses in Melanoma
2025
- Foxp3+ Regulatory T Cells Restrain Th1 Response Shielding the Brain from Lethal Inflammatory Damage during Cryptococcal Meningoencephalitis
Research Square · 2025
- Vascular normalization through histotripsy ablation therapy promotes anti-tumor immunity and enhances drug delivery in solid tumors 3610
The Journal of Immunology · 2025
- Mechanisms of iNOS-mediated protection against CNS damage in cryptococcal meningitis 3992
The Journal of Immunology · 2025
- The Journal of Immunology×26
- mBio×8
- Frontiers in Immunology×6
- Science Advances×4
- Frontiers in Microbiology×4
- Jintao Xu
Medicine · University of Michigan
- Shayanki Lahiri
Medicine · University of Michigan
- Julio C Zuniga-Moya
Medicine · University of Michigan
- John J. Osterholzer
Medicine · University of Michigan
- Kristie D. Goughenour
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile